Core Laboratories N.V.

13F holders, Q2 2024 (June 30)
1holders
0new positions
0sold out
$20.08avg. 13F price*

At the end of Q2 2024, 1 institutions reported holding Core Laboratories N.V. in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holder was AlphaMark Advisors, LLC ($24K).

Company
Core Laboratories N.V.
CUSIP
N22717107
Latest filing quarter
Q4 2024

History

Number of 13F holders

01 Q1 2024: 1Q1 2024Q2 2024: 1Q2 2024Q3 2024: 1Q3 2024Q4 2024: 1Q4 2024

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions0$0
Exits0$0

All 13F filers, Q1 2024 → Q2 2024: 355 shares sold, net −355 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

AlphaMark Advisors, LLC 0.01% Reduce -22.9% 1,195 $24K

"% of holder's portfolio" is CORE LABORATORIES N.V.'s weight in each manager's 13F, not the share of Core Laboratories N.V. the manager owns.